BRAZE INC-A (BRZE) Stock News
NASDAQ:BRZE - Nasdaq - US10576N1028 - Common Stock - Currency: USD
BRZE Latest News, Press Relases and Analysis
MarketBeat Week in Review — 04/07 - 04/11
Stocks were on track for a positive week despite the continued uncertainty surrounding tariffs, but inflation and earnings season will keep investors on alert
2 of Wall Street’s Favorite Stocks with Promising Prospects and 1 to Think Twice About
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Snowflake Boosts Growth by Doubling Down on AI
Snowflake is releasing product innovations at a blistering pace doubling last year's to over 400 capabilities to drive 126% net revenue retention rates.
PROS, Global-E, SPS Commerce Stand Out As Tariffs Reshape Software Spending Priorities: Analyst
Needham analyzed impact of tariffs on software, healthcare, media, medtech, consumer, and bitcoin mining sectors. Apple's EPS may fall by 28%.
Company News for Mar 31, 2025
Companies In The News Are: LULU, BRZE, AIR, CGON.
What's Going On With Braze Shares Friday?
Braze shares are trading higher on Friday after the company reported better-than-expected 2025 fiscal-year fourth-quarter earnings on Thursday.
Q4 Earnings Highlights: Braze (NASDAQ:BRZE) Vs The Rest Of The Sales And Marketing Software Stocks
Let’s dig into the relative performance of Braze (NASDAQ:BRZE) and its peers as we unravel the now-completed Q4 sales and marketing software earnings season.
Braze (BRZE) Narrows Q4 Losses with 22.5% Revenue Boost and AI-Driven Innovation
We recently published a list of Top 8 AI News Updates on Wall Street’s Radar. In this article, we are going to take a look at where Braze Inc. (NASDAQ:BRZE) stands against other top AI news updates on Wall Street’s radar. As xAI’s Grok became the top app on the Google Play Store, its owner, […]
Icon Energy to effect 1-for-40 reverse stock split
Icon Energy (ICON) announced an update on certain corporate matters and that its board of directors has determined to effect a 1-for-40 reverse stock split of the Company’s issued common shares par value $0.001 effective at the opening of trading on April 1, 2025. On January 24, 2025, the Company announced the closing of its $12M public offering of units containing Common Shares and warrants to purchase Common Shares, as set forth in more detail in the Company’s registration statement on Form F-
Why Braze Stock Popped Today
Milestone CRL affirms integrity of clinical data, says H.C. Wainwright
H.C. Wainwright keeps a Buy rating on Milestone Pharmaceuticals (MIST) after the company announced receipt of a complete response letter from the FDA regarding its new drug application for its etripamil nasal spray for the treatment of paroxysmal supraventricular tachycardia. While “disappointed,” the firm says the issues raised were exclusively related to chemistry, manufacturing, and controls, with no concerns cited around the clinical efficacy or safety of etripamil. This reaffirms the integr
Braze price target raised to $55 from $50 at Citi
Citi raised the firm’s price target on Braze (BRZE) to $55 from $50 and keeps a Buy rating on the shares after the company “delivered a strong finish to FY25” and gave FY26 organic growth guidance of 16%, which does not include the contribution from the OfferFit acquisition, that was better-than-expected. The company also announced it will acquire AI decisioning-engine startup OfferFit, which tripled revenue last year, leading the firm to “believe there is healthy room for upside to numbers,” th
Humacyte price target lowered to $8 from $10 at BTIG
BTIG lowered the firm’s price target on Humacyte (HUMA) to $8 from $10 and keeps a Buy rating on the shares post the Q4 report. The firm cites the company’s increased share count for the target cut. The analyst views Humacyte’s early commercial traction as evidence of the “game-changing nature” of its Acellular Tissue Engineered Vessel. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >>
Lulu’s Fashion Lounge price target lowered to $1 from $2 at Telsey Advisory
Telsey Advisory analyst Dana Telsey lowered the firm’s price target on Lulu’s Fashion Lounge (LVLU) to $1 from $2 and keeps a Market Perform rating on the shares. The company delivered an EBITDA beat for Q4, driven by better-than-expected gross margin performance and tighter expense control, the analyst tells investors. While the firm is encouraged by the company’s FY25 outlook for its adjusted EBITDA, the challenged topline hinders a more robust turnaround, the firm adds. Published first on The
Why Bristol-Myers Squibb Co. (BMY) Went Up On Friday?
We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a look at where Bristol-Myers Squibb Co. (NYSE:BMY) stands against other firms that end Friday strong. Wall Street’s main indices finished the trading week in the negative territory as investor sentiment was […]
Why PPL Corporation (PPL) Went Up On Friday?
We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a look at where PPL Corporation (NYSE:PPL) stands against other firms that end Friday strong. Wall Street’s main indices finished the trading week in the negative territory as investor sentiment was weighed […]
Why Braze Inc. (BRZE) Went Up On Friday?
We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a look at where Braze Inc. (NASDAQ:BRZE) stands against other firms that end Friday strong. Wall Street’s main indices finished the trading week in the negative territory as investor sentiment was weighed […]
Why Soleno Therapeutics Inc. (SLNO) Went Up On Friday?
We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other firms that end Friday strong. Wall Street’s main indices finished the trading week in the negative territory as investor sentiment was […]
Is Thermo Fisher Scientific (TMO) The Most Expensive Stock Insiders Are Dumping In March?
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against other most expensive stocks insiders are dumping in March. After being in the green for a few trading sessions, the broader […]
Why Braze Stock Popped Today
Shares of Braze (NASDAQ: BRZE), a customer engagement platform company, spiked Friday morning after the company's fiscal 2025 fourth-quarter results blew past analysts' consensus estimates. Braze reported revenue of $160.4 million in the quarter, an increase of nearly 23% from the year-ago quarter, and ahead of Wall Street's consensus estimate of $155.7 million. Braze reported non-GAAP earnings per share of $0.12, up from a loss of $0.04 in the year-ago quarter and far ahead of analysts' consensus estimate of $0.05 per share.
Braze's Fiscal Q4 Results Top Forecast
The customer engagement platform company beat adjusted earnings expectations and delivered strong revenue growth, but its dollar-based net retention rate slid.
Braze, Inc. (BRZE) Beats Q4 Earnings and Revenue Estimates
Braze (BRZE) delivered earnings and revenue surprises of 140% and 3.10%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: SHCO
Braze Reports Fiscal Year and Fourth Quarter 2025 Results
